REACTINE EYE DROPS
REACTINE EYE DROPS
Approved
DIN Number
02237000
Drug Class
Human
Market Date
N/A
Company
HC
mcneil consumer healthcare division of johnson & johnson inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02237000
AIG Number0213722002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
S01GA51 NAPHAZOLINE, COMBINATIONS
Product Specifications
Dosage FormDrops
Route of AdministrationOphthalmic
AHFS Classification52:32.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
NAPHAZOLINE HYDROCHLORIDEActive
Strength: 0.025 % / W/V
Monograph: NAPHAZOLINE HYDROCHLORIDE
PHENIRAMINE MALEATEActive
Strength: 0.3 % / W/V
Monograph: PHENIRAMINE MALEATE